Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 26;5(3):e605.
doi: 10.1002/hsr2.605. eCollection 2022 May.

Drug absorption in bariatric surgery patients: A narrative review

Affiliations
Review

Drug absorption in bariatric surgery patients: A narrative review

Abdullah Abdulaziz Alalwan et al. Health Sci Rep. .

Abstract

Background: Despite the increase in the number of bariatric surgeries performed, little is known about the impact of the surgery on drug absorption. Unpredictability is assumed with drugs, given the anatomical changes after surgery.

Objective: To evaluate the impact of bariatric surgery on drug absorption based on the type of procedure performed.

Methods: We conducted a comprehensive literature review searching PubMed/Medline for published studies (from inception to December 2017) that evaluate the use of drugs and the assessment of drug absorption after bariatric surgery. Pharmacokinetic/pharmacodynamic studies, case reports, and observational studies were included in our review.

Results: We found 60 studies addressing drug use after bariatric surgery. Twenty-eight studies reported a decrease in drug absorption after bariatric surgery while only four studies showed an increase in drug absorption. Unchanged absorption of drugs was seen in 23 studies after the surgery.

Conclusion: The available information shows variations in drug absorption after bariatric surgery. The unpredictability may result from factors related to the patient, drug, and/or type of surgery. Therefore, pharmacists' involvement and close monitoring of patients after bariatric surgery could be effective to avoid sub-/supratherapeutic responses.

Keywords: bariatric surgery; drug absorption; drug use; pharmacotherapy; therapeutics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Alalwan AA, Friedman J, Park H, Segal R, Brumback BA, Hartzema AG. US national trends in bariatric surgery: a decade of study. Surgery. 2021;170(1):13‐17. - PubMed
    1. Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity. 2013;21:S1‐S27. - PMC - PubMed
    1. O'Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program. Ann Intern Med. 2006;144(9):625. - PubMed
    1. Geraldo M, Feder D, Affonso Fonseca FL, de Fatima Veiga Gouveia MR. The use of drugs in patients who have undergone bariatric surgery. Int J Gen Med. 2014;7:219‐224. - PMC - PubMed
    1. Abeles D, Shikora S. Bariatric surgery: current concepts and future directions. Aesthetic Surg J. 2008;28(1):79‐84. - PubMed

LinkOut - more resources